Fluidigm Expects 19 Percent Revenue Decline in Q4 | GenomeWeb

NEW YORK (GenomeWeb) – Fluidigm today announced an approximately 19 percent decline in total revenue for the fourth quarter of 2016, among other preliminary financial results.

For the three months ended Dec. 31, the South San Francisco instrumentation firm expects between $24.7 million and $25.2 million in revenues, down from $30.7 million a year ago. On average, analysts are expecting total Q4 revenues of $26.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.